Kearney’s 2026 Reshoring Index remains in negative territory
Despite record investment and tariffs, US manufacturing imports rise, while domestic manufacturing output barely shifts Kearney’s Reshoring Index remains... Read more.
Albert Drives Smarter Shelf Execution with AI-Powered Inventory Scanning from Brain Corp
The automated shelf-scanning technology enables the major retailer to dynamically identify out-of-stocks and pricing errors — eliminating reliance on manual corrections... Read more.
Rula Unpacks the Modern Mental Health Maze in New 2026 Report
The brand’s 2026 State of Mental Health Report reveals the widening gaps, barriers, and evolving behaviors shaping mental health in America LOS ANGELES, April... Read more.
Haas Automation Selects TransPerfect’s GlobalLink Connector for HubSpot
Integration Supports 65 Million Annual Emails Across Seven Languages, Cutting Campaign Build Time by 50% Key Takeaways Haas Automation reduces campaign build time... Read more.
Canadian pension plans gained 0.4% in Q1 as energy surge cushioned technology selloff
TORONTO, April 29, 2026 /CNW/ – RBC Investor Services (RBCIS) reported that Canadian defined benefit (DB) pension plans under its administration posted a median... Read more.
KPMG expands agentic AI capabilities to support Canadian business transformation
KPMG’s investments help organizations turn AI ideas into real-world results TORONTO, April 29, 2026 /CNW/ – KPMG Canada continues to grow its investments... Read more.
R3 Continuum Expands Clinical Leadership Team to Accelerate Growth and Market Impact
BLOOMINGTON, Minn., April 29, 2026 /PRNewswire/ — R3 Continuum today announced the expansion of its senior clinical leadership team with the appointments... Read more.
Cure Launches First National Index Revealing What it Takes to Turn Science into Cures
Success factors go beyond funding, publications and patents to identify the top-ranked 303 U.S. Research Institutions making real-world impact NEW YORK, April 29,... Read more.
Vivacta Bio Closed Series A and Series A+ Financing of Over US$50 Million
Backed by Decheng Capital, Loyal Valley Capital, OrbiMed, and Other Renowned Investors SHANGHAI, April 29, 2026 /PRNewswire/ — Vivacta Biotechnology (Shanghai)... Read more.
From Pilot to Production: Axtria and LangChain Partner to Govern and Scale AI Agents in Pharma
Axtria’s pharma-native AgentOps framework and LangChain’s leading agent development platform help life sciences enterprises deploy AI agents with confidence... Read more.